Search Results - "Novo Nordisk"

Developments in the Management of Growth Hormone Deficiency: Clinical Utility of Somapacitan by Miller BS, Blair J, Horikawa R, Linglart A, Yuen KC

Connect to this object online.

Cost minimization analysis of different growth hormone pen devices based on time-and-motion simulations by Kim Jaewhan, Haak Sandra W, Nickman Nancy A

Connect to this object online.

A global quantitative survey of hemostatic assessment in postpartum hemorrhage and experience with associated bleeding disorders by James AH, Cooper DL, Paidas MJ

Connect to this object online.

Prognostic utility of Fibrosis-4 Index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and/or type 2 diabetes: a longitu... by Quentin M. Anstee, Tina L. Berentzen, Louise M. Nitze, Maximilian Jara, Anders B. Jensen, Mette S. Kjær, Kamal K. Mangla, Jens M. Tarp, Kamlesh Khunti

Connect to this object online.

Healthcare Costs of Diabetes and Microvascular and Macrovascular Disease in Individuals with Incident Type 2 Diabetes Mellitus: A Ten-Year Longitudinal Study by Visaria J, Iyer NN, Raval AD, Kong SX, Hobbs T, Bouchard J, Kern DM, Willey VJ

Connect to this object online.

Gender Differences in the Attitudes and Management of People with Obesity in Saudi Arabia: Data from the ACTION-IO Study by Almubark RA, Alqahtani S, Isnani AC, Alqarni A, Shams M, Yahia M, Alfadda AA

Connect to this object online.